Clinical aspects of hepatitis B virus infection

[1]  D. Tyrrell.  Phase II trial of lamivudine for chronic hepatitis B , 1993 .

[2]  D. V. van Thiel,et al.  Fibrosing cholestatic hepatitis in a transplant recipient with hepatitis B virus precore mutant. , 1993, Gastroenterology.

[3]  A. Detsky,et al.  Effect of Alpha-Interferon Treatment in Patients with Hepatitis B e Antigen-Positive Chronic Hepatitis B , 1993, Annals of Internal Medicine.

[4]  T. Ishikawa,et al.  Pilot study of ribavirin and interferon‐β for chronic hepatitis B , 1993 .

[5]  J. Bartolomé,et al.  Levamisole and interferon in children with chronic hepatitis B , 1993, Hepatology.

[6]  C. Riely,et al.  Increased hepatocyte expression of hepatitis B virus transcription in patients with features of fibrosing cholestatic hepatitis. , 1993, Gastroenterology.

[7]  H. Tsukuma,et al.  Risk factors for hepatocellular carcinoma among patients with chronic liver disease. , 1993, The New England journal of medicine.

[8]  H. Inskip,et al.  Efficacy of hepatitis B vaccine in the Gambian expanded programme on immunisation , 1993, The Lancet.

[9]  J. Hoofnagle,et al.  Interferon alfa for patients with clinically apparent cirrhosis due to chronic hepatitis B. , 1993, Gastroenterology.

[10]  B. Bloom,et al.  A Reappraisal of Hepatitis B Virus Vaccination Strategies Using Cost-Effectiveness Analysis , 1993, Annals of Internal Medicine.

[11]  W. Schaffner,et al.  Hepatitis B Immunization Strategies: Expanding the Target , 1993, Annals of Internal Medicine.

[12]  E. Domingo,et al.  Viral genetic variation: hepatitis B virus as a clinical example , 1993, The Lancet.

[13]  G. Meucci,et al.  The Natural History of Asymptomatic Hepatitis B Surface Antigen Carriers , 1993, Annals of Internal Medicine.

[14]  C. Bréchot,et al.  Persistence of Hepatitis B and Hepatitis C Viral Genomes in Primary Liver Cancers from HBsAg‐Negative Patients: A Study of a Low‐endemic Area , 1993, Hepatology.

[15]  B. Scharschmidt,et al.  Hepatitis B in Patients with HIV Infection: Relationship to AIDS and Patient Survival , 1992, Annals of Internal Medicine.

[16]  Randall G. Lee,et al.  Fibrosing cytolytic liver failure secondary to recurrent hepatitis B after liver transplantation. , 1992, Gastroenterology.

[17]  L. Ferrell,et al.  Hepatitis B virus and apparent fulminant non-A, non-B hepatitis , 1992, The Lancet.

[18]  B. Housset,et al.  Interactions between human immunodeficiency virus‐1, hepatitis delta virus and hepatitis B virus infections in 260 chronic carriers of hepatitis B virus , 1992, Hepatology.

[19]  S. Davies,et al.  High-level expression of hepatitis B viral antigens in fibrosing cholestatic hepatitis. , 1992, Gastroenterology.

[20]  S. Davies,et al.  Hepatitis B virus reinfection after orthotopic liver transplantation. Serological and clinical implications. , 1992, Journal of hepatology.

[21]  J. Hoofnagle,et al.  Thymosin treatment of chronic hepatitis B: A placebo‐controlled pilot trial , 1991, Hepatology.

[22]  J. Wands,et al.  Persistence of hepatitis B viral DNA after serological recovery from hepatitis B virus infection , 1991, Hepatology.

[23]  J. Wands,et al.  A hepatitis B virus mutant associated with an epidemic of fulminant hepatitis. , 1991, The New England journal of medicine.

[24]  J. Hoofnagle,et al.  Long-term remission of chronic hepatitis B after alpha-interferon therapy. , 1991, Annals of internal medicine.

[25]  D. Samuel,et al.  Passive immunoprophylaxis after liver transplantation in HBsAg-positive patients , 1991, The Lancet.

[26]  D. V. van Thiel,et al.  Orthotopic liver transplantation for patients with hepatitis B virus–related liver disease , 1991, Hepatology.

[27]  S. Hadler,et al.  Outcome of hepatitis B virus infection in homosexual men and its relation to prior human immunodeficiency virus infection. , 1991, The Journal of infectious diseases.

[28]  A. Lok,et al.  Interferon alfa therapy in patients with chronic hepatitis B virus infection. Effects on hepatitis B virus DNA in the liver. , 1991, Gastroenterology.

[29]  A. Lok,et al.  Reactivation of hepatitis B virus replication in patients receiving cytotoxic therapy. Report of a prospective study. , 1991 .

[30]  P. Roingeard,et al.  Hepatitis B virus core antigen (HBc Ag) accumulation in an HBV nonproducer clone of HepG2-transfected cells is associated with cytopathic effect. , 1990, Virology.

[31]  E. Schiff,et al.  A Randomized, Controlled Trial of Interferon Alfa-2b Alone and after Prednisone Withdrawal for the Treatment of Chronic Hepatitis B , 1990 .

[32]  J. Wands,et al.  Characterization and biological properties of a hepatitis B virus isolated from a patient without hepatitis B virus serologic markers , 1990, Hepatology.

[33]  H. Margolis,et al.  The Changing Epidemiology of Hepatitis B in the United States: Need for Alternative Vaccination Strategies , 1990 .

[34]  R. Palmiter,et al.  Molecular pathogenesis of hepatocellular carcinoma in hepatitis B virus transgenic mice , 1989, Cell.

[35]  H. Thomas,et al.  Which patients with chronic hepatitis B virus infection will respond to α‐interferon therapy? A statistical analysis of predictive factors , 1989, Hepatology.

[36]  A. Lok,et al.  Treatment of Chronic Hepatitis B with Interferon: Experience in Asian Patients , 1989, Seminars in liver disease.

[37]  P. Hofschneider,et al.  β- and γ-Interferon in Chronic Active Hepatitis B: A Pilot Trial of Short-Term Combination Therapy , 1989 .

[38]  G. Gerken,et al.  Treatment of patients with chronic type B hepatitis and concurrent human immunodeficiency virus infection with a combination of interferon alpha and azidothymidine: a pilot study. , 1989, Digestion.

[39]  J. Hoofnagle,et al.  Randomized, controlled trial of recombinant human α-interferon in patients with chronic hepatitis B , 1988 .

[40]  M. Kreek,et al.  Hepatitis D virus and human immunodeficiency virus antibodies in parenteral drug abusers who are hepatitis B surface antigen positive. , 1988, The Journal of infectious diseases.

[41]  F. Carnot,et al.  Hepatitis B virus and hepatitis B-related viral infection in renal transplant recipients. A prospective study of 90 patients. , 1988, Gastroenterology.

[42]  G. Garcia,et al.  Adenine arabinoside monophosphate (vidarabine phosphate) in combination with human leukocyte interferon in the treatment of chronic hepatitis B. A randomized, double-blinded, placebo-controlled trial. , 1987, Annals of internal medicine.

[43]  Heather M. Smith,et al.  Loss of HBsAg with interferon‐α therapy in chronic hepatitis D virus infection , 1993, Journal of medical virology.

[44]  A. Lok,et al.  Spontaneous hepatitis B e antigen to antibody seroconversion and reversion in Chinese patients with chronic hepatitis B virus infection. , 1987, Gastroenterology.

[45]  O. Weiland,et al.  Treatment of fulminant hepatitis B and fulminant hepatitis B and D coinfection with foscarnet. , 1987, Progress in clinical and biological research.

[46]  T. Merigan,et al.  Survival in chronic hepatitis B. An analysis of 379 patients. , 1984, Annals of internal medicine.